vs
Side-by-side financial comparison of OSR Holdings, Inc. (OSRH) and SenesTech, Inc. (SNES). Click either name above to swap in a different company.
OSR Holdings, Inc. is the larger business by last-quarter revenue ($627.7K vs $421.0K, roughly 1.5× SenesTech, Inc.). SenesTech, Inc. runs the higher net margin — -428.5% vs -508.9%, a 80.4% gap on every dollar of revenue. On growth, SenesTech, Inc. posted the faster year-over-year revenue change (-16.0% vs -23.7%).
SenesTech, Inc. is an agricultural biotechnology life-sciences company, specializing in fertility management as a form of pest control. The company's primary product, ContraPest is designed to make brown and black rats infertile. SenesTech is headquartered in Phoenix, Arizona.
OSRH vs SNES — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $627.7K | $421.0K |
| Net Profit | $-3.2M | $-1.8M |
| Gross Margin | 41.7% | 55.3% |
| Operating Margin | -605.9% | -446.8% |
| Net Margin | -508.9% | -428.5% |
| Revenue YoY | -23.7% | -16.0% |
| Net Profit YoY | -1283.3% | -43.7% |
| EPS (diluted) | $0.12 | $0.48 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $421.0K | ||
| Q3 25 | $627.7K | $690.0K | ||
| Q2 25 | $1.1M | $625.0K | ||
| Q1 25 | $761.3K | $485.0K | ||
| Q4 24 | — | $501.0K | ||
| Q3 24 | $823.0K | $482.0K | ||
| Q2 24 | $881.8K | $459.0K | ||
| Q1 24 | $910.2K | $415.0K |
| Q4 25 | — | $-1.8M | ||
| Q3 25 | $-3.2M | $-1.3M | ||
| Q2 25 | $-5.2M | $-1.6M | ||
| Q1 25 | $-11.4M | $-1.7M | ||
| Q4 24 | — | $-1.3M | ||
| Q3 24 | $-231.0K | $-1.5M | ||
| Q2 24 | $-97.3K | $-1.6M | ||
| Q1 24 | $-60.4K | $-1.8M |
| Q4 25 | — | 55.3% | ||
| Q3 25 | 41.7% | 62.8% | ||
| Q2 25 | 2.9% | 65.4% | ||
| Q1 25 | 22.2% | 64.5% | ||
| Q4 24 | — | 60.9% | ||
| Q3 24 | 21.8% | 65.4% | ||
| Q2 24 | 26.3% | 54.2% | ||
| Q1 24 | 26.3% | 32.5% |
| Q4 25 | — | -446.8% | ||
| Q3 25 | -605.9% | -195.2% | ||
| Q2 25 | -460.5% | -258.2% | ||
| Q1 25 | -383.3% | -342.9% | ||
| Q4 24 | — | -250.9% | ||
| Q3 24 | -433.4% | -321.0% | ||
| Q2 24 | -364.0% | -349.0% | ||
| Q1 24 | -362.8% | -444.1% |
| Q4 25 | — | -428.5% | ||
| Q3 25 | -508.9% | -188.1% | ||
| Q2 25 | -460.2% | -258.6% | ||
| Q1 25 | -1496.5% | -343.3% | ||
| Q4 24 | — | -250.5% | ||
| Q3 24 | -28.1% | -313.9% | ||
| Q2 24 | -11.0% | -345.1% | ||
| Q1 24 | -6.6% | -441.4% |
| Q4 25 | — | $0.48 | ||
| Q3 25 | $0.12 | $-0.28 | ||
| Q2 25 | — | $-0.87 | ||
| Q1 25 | — | $-1.28 | ||
| Q4 24 | — | $-0.15 | ||
| Q3 24 | $-0.06 | $-2.07 | ||
| Q2 24 | $-0.02 | $-3.08 | ||
| Q1 24 | $-0.01 | $-3.56 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.2M | $8.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $134.2M | $9.6M |
| Total Assets | $177.3M | $12.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $8.6M | ||
| Q3 25 | $2.2M | $10.2M | ||
| Q2 25 | $1.6M | $6.1M | ||
| Q1 25 | $1.6M | $1.7M | ||
| Q4 24 | — | $1.3M | ||
| Q3 24 | $12.2K | $2.5M | ||
| Q2 24 | $119.1K | $2.0M | ||
| Q1 24 | $3.6K | $3.6M |
| Q4 25 | — | $9.6M | ||
| Q3 25 | $134.2M | $11.3M | ||
| Q2 25 | $139.2M | $7.0M | ||
| Q1 25 | $132.3M | $2.9M | ||
| Q4 24 | — | $2.5M | ||
| Q3 24 | $-5.8M | $3.7M | ||
| Q2 24 | $-4.9M | $3.1M | ||
| Q1 24 | $-4.3M | $4.6M |
| Q4 25 | — | $12.8M | ||
| Q3 25 | $177.3M | $14.6M | ||
| Q2 25 | $185.4M | $10.4M | ||
| Q1 25 | $174.6M | $3.6M | ||
| Q4 24 | — | $3.3M | ||
| Q3 24 | $20.9M | $4.4M | ||
| Q2 24 | $20.6M | $4.0M | ||
| Q1 24 | $37.3M | $5.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-2.7M | $-1.7M |
| Free Cash FlowOCF − Capex | — | $-1.7M |
| FCF MarginFCF / Revenue | — | -398.3% |
| Capex IntensityCapex / Revenue | — | 3.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-5.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-1.7M | ||
| Q3 25 | $-2.7M | $-1.4M | ||
| Q2 25 | $-482.6K | $-1.1M | ||
| Q1 25 | $-64.1K | $-1.6M | ||
| Q4 24 | — | $-1.2M | ||
| Q3 24 | $-686.5K | $-1.4M | ||
| Q2 24 | $-483.2K | $-1.6M | ||
| Q1 24 | $-498.8K | $-1.8M |
| Q4 25 | — | $-1.7M | ||
| Q3 25 | — | $-1.4M | ||
| Q2 25 | — | $-1.2M | ||
| Q1 25 | — | $-1.6M | ||
| Q4 24 | — | $-1.2M | ||
| Q3 24 | — | $-1.4M | ||
| Q2 24 | — | $-1.6M | ||
| Q1 24 | — | $-1.8M |
| Q4 25 | — | -398.3% | ||
| Q3 25 | — | -205.9% | ||
| Q2 25 | — | -191.5% | ||
| Q1 25 | — | -328.5% | ||
| Q4 24 | — | -246.1% | ||
| Q3 24 | — | -296.1% | ||
| Q2 24 | — | -354.2% | ||
| Q1 24 | — | -441.2% |
| Q4 25 | — | 3.1% | ||
| Q3 25 | — | 6.1% | ||
| Q2 25 | — | 7.5% | ||
| Q1 25 | — | 7.4% | ||
| Q4 24 | — | 3.0% | ||
| Q3 24 | — | 5.8% | ||
| Q2 24 | — | 8.5% | ||
| Q1 24 | — | 0.5% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.